comparemela.com
Latest Breaking News On - Shenzhen small molecule early rd center - Page 1 : comparemela.com
National Medical Products Administration (NMPA) Approves Chipscreen Bioscience's Chidamide (Epidaza) combined with R-CHOP for the treatment of diffuse large B-cell lymphoma
/PRNewswire/ Shenzhen Chipscreen Biosciences Co., Ltd. (Chipscreen Biosciences, Stock Symbol: 688321.SH) announced that the company s lead innovative.
Feng-wang
Hunan
China
Shanghai
Shenzhen
Guangdong
Chengdu
Sichuan
United-states
Japan
Beijing
Taiwan
vimarsana © 2020. All Rights Reserved.